Kintor Pharmaceutical Statistics
Total Valuation
KNTPF has a market cap or net worth of 138.55 million. The enterprise value is 136.42 million.
| Market Cap | 138.55M |
| Enterprise Value | 136.42M |
Important Dates
The next estimated earnings date is Wednesday, August 27, 2025.
| Earnings Date | Aug 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 454.87M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 380.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 202.26 |
| PB Ratio | 3.44 |
| P/TBV Ratio | 6.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.41 |
| EV / Sales | 200.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.96 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.45.
| Current Ratio | 1.03 |
| Quick Ratio | 0.99 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.66 |
| Interest Coverage | -15.73 |
Financial Efficiency
Return on equity (ROE) is -41.29% and return on invested capital (ROIC) is -16.01%.
| Return on Equity (ROE) | -41.29% |
| Return on Assets (ROA) | -13.17% |
| Return on Invested Capital (ROIC) | -16.01% |
| Return on Capital Employed (ROCE) | -41.87% |
| Revenue Per Employee | 4,077 |
| Profits Per Employee | -126,640 |
| Employee Count | 168 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KNTPF has paid 2,466 in taxes.
| Income Tax | 2,466 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +336.29% in the last 52 weeks. The beta is -0.19, so KNTPF's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | +336.29% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 59.28 |
| Average Volume (20 Days) | 5,244 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KNTPF had revenue of 685,016 and -21.28 million in losses. Loss per share was -0.05.
| Revenue | 685,016 |
| Gross Profit | 257,429 |
| Operating Income | -19.99M |
| Pretax Income | -21.27M |
| Net Income | -21.28M |
| EBITDA | -18.19M |
| EBIT | -19.99M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 20.37 million in cash and 18.22 million in debt, giving a net cash position of 2.15 million.
| Cash & Cash Equivalents | 20.37M |
| Total Debt | 18.22M |
| Net Cash | 2.15M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.29M |
| Book Value Per Share | 0.09 |
| Working Capital | 692,003 |
Cash Flow
In the last 12 months, operating cash flow was -27.27 million and capital expenditures -210,711, giving a free cash flow of -27.49 million.
| Operating Cash Flow | -27.27M |
| Capital Expenditures | -210,711 |
| Free Cash Flow | -27.49M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 37.58% |
| Operating Margin | -2,918.00% |
| Pretax Margin | -3,105.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KNTPF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | n/a |
| Earnings Yield | -15.36% |
| FCF Yield | -19.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KNTPF has an Altman Z-Score of -10.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.39 |
| Piotroski F-Score | 1 |